NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $395,726 | +0.6% | 3,885 | -0.3% | 0.12% | +0.9% |
Q2 2023 | $393,246 | +8.2% | 3,897 | -1.3% | 0.12% | -4.2% |
Q1 2023 | $363,400 | -0.6% | 3,950 | -2.0% | 0.12% | -18.9% |
Q4 2022 | $365,511 | +19.4% | 4,029 | 0.0% | 0.15% | +20.3% |
Q3 2022 | $306,000 | -10.3% | 4,029 | 0.0% | 0.12% | -7.5% |
Q2 2022 | $341,000 | -3.7% | 4,029 | 0.0% | 0.13% | +14.7% |
Q1 2022 | $354,000 | -1.7% | 4,029 | -2.1% | 0.12% | +9.4% |
Q4 2021 | $360,000 | -3.5% | 4,114 | -9.8% | 0.11% | -15.2% |
Q3 2021 | $373,000 | -20.1% | 4,560 | -10.5% | 0.12% | -16.1% |
Q2 2021 | $467,000 | -6.6% | 5,095 | -13.0% | 0.15% | -15.3% |
Q1 2021 | $500,000 | -53.9% | 5,854 | -49.1% | 0.18% | -57.1% |
Q4 2020 | $1,085,000 | +0.9% | 11,492 | -7.1% | 0.41% | -10.9% |
Q3 2020 | $1,075,000 | -5.3% | 12,364 | -4.9% | 0.46% | -16.5% |
Q2 2020 | $1,135,000 | +20.7% | 13,000 | +14.0% | 0.55% | -18.7% |
Q1 2020 | $940,000 | -2.3% | 11,400 | +12.3% | 0.68% | +17.5% |
Q4 2019 | $962,000 | – | 10,155 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |